Current filters:


Popular Filters

1076 to 1100 of 1235 results

Taiwan pharmaceutical exports rise 6.2% in 3rd-qtr 2011


Year-on-year exports by Taiwan's pharmaceutical industry for the third quarter of this year saw a rise…

Asia-PacificGenericsMarkets & MarketingPharmaceutical

Actavis debuts generic Diovan in major European markets


Iceland-headquartered generic drug major Actavis Group revealed on Friday that it has launched Valsartan…

ActavisCardio-vascularDiovanDiovan HCTEuropeGenericsMarkets & MarketingNovartisvalsartan

Generic erosion will reduce BPH/male urinary tract drug market to $4 billion in 2010


The market for therapies that treat benign prostatic hyperplasia (BPH) and associated lower urinary tract…

Gastro-intestinalsGenericsGlobalMarkets & MarketingPharmaceutical

Lupin acquires Japanese drugmaker I’rom Pharma


Indian drugmaker Lupin (LOPN: BO) has entered into an agreement with Japanese health care provider I’rom…

Asia-PacificGenericsI'rom PharmaceuticalLupinMergers & Acquisitions

Brand drug 'Co-pay Coupons' undermine generics, raise health costs by $1.1 billion in US state of Michigan


The proliferation of brand drug "co-pay coupon" promotions, which lure insured consumers from generics…

GenericsMarkets & MarketingNorth AmericaPharmaceuticalPricing

Japan generics market: Boom or Bust? by P Reed Maurer


Japan has the lowest generic utilization rate of developed markets. Thus, as you might expect, Japan…

Asia-PacificGenericsMarkets & MarketingPricing

New legislative amendments may result in huge losses for global pharma producers in Russia


Sergei Lisovsky, a well-known Russian senator and public figure, has put forward an initiative to make…


India’s Ranbaxy posts 3rd-qtr 2011 loss


India’s largest drugmaker, Ranbaxy Laboratories (RANB: BO) posted its biggest quarterly loss in…

FinancialGenericsRanbaxy Laboratories

Letter to the Editor: Canadian intellectual property


Dear, The Pharma Letter: The characterization of the CMAJ article by Paul Grootendorst and Aidan Hollis…

GenericsNorth AmericaPatentsPharmaceutical

Kohl-Grassley generic drug bill would save US taxpayers nearly $4.8 billion, says CBO


A new estimate from the USA’s Congressional Budget Office (CBO) estimate finds that a bipartisan…

GenericsNorth AmericaPatentsPharmaceuticalPoliticsPricing

Will the USA’s Hatch-Waxman lock be sprung in 2012? asks HP&M lawyer


In the USA, there have been rumors for several weeks that, once the ball gets rolling in Congress with…

GenericsLegalNorth AmericaPharmaceuticalPoliticsRegulation

Teva to continue selling Viagra generic in Russia


Israel-basedTeva Pharmaceutical Industries (Nasdaq: TEVA) managed to avoid a high-profile confrontation…

DynamicoEuropeGenericsMarkets & MarketingPatentsPfizerPharmaceuticalReproductiveTeva Pharmaceutical IndustriesViagra

US Rep Bass introduces legislation to save taxpayer money under Medicaid


US Congressman Charles Bass (Republican, New Hampshire) has introduced bipartisan legislation in the…

GenericsLegalNorth AmericaPricing

Generics giant Teva posts 3rd-qtr 2011 sales rise but net income down 13%


The world’s largest generic drugs maker, Teva Pharmaceutical Industries (Nasdaq: TEVA), has reported…

FinancialGenericsPharmaceuticalTeva Pharmaceutical Industries

Watson posts 23% rise in 3rd-qtr 2011 net revenue; ups forecast


US generics drugmaker Watson Pharmaceuticals (NYSE: WPI) has reported net revenue of $1.1 billion for…

FinancialGenericsWatson Pharmaceuticals

Pres Obama orders FDA action to reduce Rx drug shortages in USA


in frequency and severity in recent years and adversely affecting patient care. A small number of drugs…

GenericsNorth AmericaPharmaceuticalPoliticsRegulation

1076 to 1100 of 1235 results

Back to top